The Spectrum of Epidermolysis Bullosa in KwaZulu‐Natal, South Africa
Authors:
- Antoinette ChateauACAntoinette Chateau
- Thirona NaickerTNThirona Naicker
- Cassandra Bruce‐BrandCBCassandra Bruce‐Brand
- Johann SchneiderJSJohann Schneider
- Colleen AldousColleen Aldous
- Ncoza DlovaNDNcoza Dlova
- Hui‐Ching ChengHCHui‐Ching Cheng
- Pei‐Chi LinPLPei‐Chi Lin
- Hsin‐Yu HuangHHHsin‐Yu Huang
- Chao‐Kai HsuCHChao‐Kai Hsu
- John A. McGrathJMJohn A. McGrath
Open Access
- 14 May 2025
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (8) , 1425-1433
Abstract
Background: Epidermolysis bullosa (EB) is a rare, heterogeneous genodermatosis characterized by skin fragility due to inherited defects in genes encoding proteins that maintain epidermal–dermal integrity. The severity and complications of EB vary by subtype, and no cure currently exists. The epidemiology is unknown in South Africa.Methods: This prospective observational study in KwaZulu‐Natal correlated African Zulu EB patients' phenotypic features with genotypic and histological findings. Whole‐exome sequencing, electron microscopy, and immunofluorescence mapping were used to identify EB subtypes.Results: Fourteen of the 15 patients recruited initially were confirmed to have EB, while one was excluded due to poor clinicopathological‐genetic correlation. Junctional EB (JEB) was identified in 11 patients, with 10 cases linked to a recurrent homozygous pathogenic variant in LAMB3, causing severe JEB, and one to ITGA3 with an unusual variant of interstitial lung disease, nephrotic syndrome, and EB (ILNEB). Two patients had autosomal dominant EB simplex, both with heterozygous KRT14 variants, and one had dominant dystrophic EB associated with a heterozygous COL7A1 variant. Eleven patients presented during the neonatal period, with a mean survival of four weeks, highlighting a high mortality rate, especially in the severe JEB cases. The cohort exhibited a balanced sex distribution, with no clear cases of consanguinity observed.Conclusion: JEB, with a recurrent pathogenic variant in LAMB3, emerged as the predominant subtype among African Zulu patients, underscoring the critical need for early diagnosis and tailored management strategies in resource‐limited settings. Integrating clinicopathological and genetic data is essential for accurate diagnosis and prognosis, emphasizing the importance of advanced diagnostic tools in improving outcomes for EB patients in South Africa.Keywords
Funding Information
- College of Health Sciences, University of KwaZulu-Natal
This publication has 18 references indexed in Scilit:
- Inherited epidermolysis bullosa: update on the clinical and genetic aspectsAnais Brasileiros de Dermatologia, 2020
- Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragilityBritish Journal of Dermatology, 2020
- Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosaBritish Journal of Dermatology, 2019
- Development of a clinical diagnostic matrix for characterizing inherited epidermolysis bullosaBritish Journal of Dermatology, 2017
- Genetic Counseling in Epidermolysis BullosaDermatologic Clinics, 2010
- Novel and recurrent mutations in Keratin 5 and 14 in Korean patients with Epidermolysis bullosa simplexJournal of Dermatological Science, 2010
- Extracutaneous manifestations and complications of inherited epidermolysis bullosaJournal of the American Academy of Dermatology, 2009
- Extracutaneous manifestations and complications of inherited epidermolysis bullosaJournal of the American Academy of Dermatology, 2009
- Genetic basis of lethal junctional epidermolysis bullosa in an affected fetus: Implications for prenatal diagnosis in one familyPrenatal Diagnosis, 1995
- A Glycine-to-Arginine Substitution in the Triple-Helical Domain of Type VII Collagen in a Family with Dominant Dystrophic Epidermolysis BullosaJournal of Investigative Dermatology, 1995